S92G.DE
Latest Trade
42.48EURChange
--(--)Today's Range
-
--52 Week Range
-
71.80As of on the XETRA ∙ Minimum 15 minute delay
Previous Close | 42.48 |
|---|---|
Open | -- |
Volume | -- |
3M AVG Volume | 3.07 |
Today's High | -- |
Today's Low | -- |
52 Week High | 71.80 |
52 Week Low | 24.68 |
Shares Out (MIL) | 34.70 |
Market Cap (MIL) | 1,483.08 |
Forward P/E | 49.81 |
Dividend (Yield %) | 0.70 |
SMA Solar Affirms 2021 Guidance after Q1 Earnings Jump
SMA Solar FY Net Loss Turns To Profit Of EUR 28.1 Million
SMA Solar Technology FY EBITDA At About EUR 72 Mln
SMA Solar Technology AG is a Germany-based developer of photovoltaic (PV) system technology. The Company operates through five segments: Residential, Commercial, Utility, Off-Grid and Storage and Service. The Residential segment focuses on small PV systems for private applications with micro and string inverters, energy management solutions, storage systems and communication products and accessories. The Commercial segment provides three-phase string inverters, energy management solutions, medium-voltage technology and other accessories. The Utility segment specializes in large-scale PV power plants with central inverters, and also provides grid services. The Off-Grid and Storage segment offers system technology for the integration of different battery technologies and power classes and collaborates with battery manufacturers and companies in the automotive industry. The Service segment comprises service and maintenance, operational management and the spare parts business.
Industry
Semiconductors
Executive Leadership
Uwe Kleinkauf
Chairman of the Supervisory Board
Juergen Reinert
Chief Executive Officer, Chief Operating Officer, Chief Technology Officer, Member of the Management Board
Kim Fausing
Deputy Chairman of the Supervisory Board, Shareholder Representative
Ulrich Hadding
Chief Financial, Human Resources and Legal Officer
Alexa Hergenroether
Independent Member of the Supervisory Board, Shareholder Representative
Price To Earnings (TTM) | 40.78 |
|---|---|
Price To Sales (TTM) | 1.51 |
Price To Book (MRQ) | 3.30 |
Price To Cash Flow (TTM) | 18.66 |
Total Debt To Equity (MRQ) | 9.25 |
LT Debt To Equity (MRQ) | 6.46 |
Return on Investment (TTM) | -- |
Return on Equity (TTM) | 6.08 |
* VAXXEL ACQUIRES TRANSGENE'S DUCKCELT®-T17 CELL LINE TO DEVELOP INDUSTRIAL-SCALE VACCINES AGAINST RESPIRATORY VIRUSES
Roche's spinal muscular atrophy (SMA) drug risdiplam hit another clinical trial target, the Swiss drugmaker said on Thursday, which analysts said bolsters its prospects of reaching $2 billion in annual sales.
SMA Solar, Germany's largest solar group, on Monday named Juergen Reinert, deputy chief executive and board member for operations and technology, as its new CEO, replacing Pierre-Pascal Urbon, who is leaving after seven years at the helm.
* Shares fall to lowest level since late-July 2017 (Recasts, adds shares, context)
SMA Solar, Germany's largest solar company, on Thursday said it expected a shortage of chips needed for the production of solar inverters to ease in the second half of the year, which the company said would lead to higher sales.
A drug being co-developed by Roche to treat spinal muscular atrophy (SMA) helped improve development scores in babies with the genetic disease, a study released on Monday showed, as the race heats up for therapies destined to be among the drug industry's most expensive.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.